The AtheroGxOne™ is a comprehensive NGS based genetic test to detect mutations in 84 genes responsible for monogenic diseases of early atherosclerosis. These diseases include:
- Premature coronary artery disease (men < 50 years old; women < 60 years old)
- Familial Hypercholesterolemia
- Familial Hypertriglyceridemia
- Mixed Hyperlipidemias
In addition, the panel screens for mutations related to Maturity-Onset Diabetes of the Young (MODY)
A comprehensive genetic test to aid in risk assessment and diagnosis of early Atherosclerosis.
28, 000 papers on inherited cardiovascular diseases(400 added monthly).
Approximately 40,000 families.
300,000 genetic variants.
Results by Leading Cardiologists
Clear, accurate and thorough clinical interpretation created by a team of leading cardiologists.
Cuttting Edge Technology
Advanced Next-Generation sequencing technology and propriety bioinformatics analysis.